Takeshi Ogo

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Polycyclic Aromatic Hydrocarbons

Advanced Cancer

Pulmonary Hypertension

Top Venues

Journal of the American Heart Association

European heart journal

European heart journal. Case reports

Proceedings of the National Academy of Sciences of the United States of America

This page only lists publications with an associated author ORCID identifier.

Publications

Takatoyo Kiko, Ryotaro Asano, Tomohiko Ishibashi, Hiroyuki Endo, Naruhiro Nishi, Hiroya Hayashi, Jin Ueda, Tatsuo Aoki, Akihiro Tsuji, Yoshikazu Nakaoka, Takeshi Ogo
Prevalence and Clinical Characteristics of Heterozygous RNF213 p.Arg4810Lys Variant Carriers Diagnosed With Chronic Thromboembolic Pulmonary Hypertension. Journal of the American Heart Association (2024)
Takatoyo Kiko, Ryotaro Asano, Tomohiko Ishibashi, Hiroyuki Endo, Naruhiro Nishi, Hiroya Hayashi, Jin Ueda, Tatsuo Aoki, Akihiro Tsuji, Yoshikazu Nakaoka, Takeshi Ogo
Prevalence and Clinical Characteristics of Heterozygous RNF213 p.Arg4810Lys Variant Carriers Diagnosed With Chronic Thromboembolic Pulmonary Hypertension. Journal of the American Heart Association 13 (15) (2024)
Ryo Takano, Akihiro Tsuji, Takeshi Ogo
A beaded ductus arteriosus aneurysm in tetralogy of Fallot with pulmonary atresia after palliative surgery. European heart journal (2023)
Satoshi Higuchi, Hiroki Horinouchi, Tatsuo Aoki, Tatsuya Nishii, Yasutoshi Ota, Jin Ueda, Akihiro Tsuji, Hideki Ota, Takeshi Ogo, Tetsuya Fukuda
Balloon Pulmonary Angioplasty in the Management of Chronic Thromboembolic Pulmonary Hypertension. Radiographics : a review publication of the Radiological Society of North America, Inc 42 (6) (2022)
Kyoko Hirakawa, Tatsuo Aoki, Akihiro Tsuji, Takeshi Ogo
Pulmonary arterial hypertension sensitive to calcium channel blocker, but not advanced pulmonary hypertension treatment: a case report. European heart journal. Case reports 6 (9) (2022)
Takeshi Masaki, Makoto Okazawa, Ryotaro Asano, Tadakatsu Inagaki, Tomohiko Ishibashi, Akiko Yamagishi, Saori Umeki-Mizushima, Manami Nishimura, Yusuke Manabe, Hatsue Ishibashi-Ueda, Manabu Shirai, Hirotsugu Tsuchimochi, James T Pearson, Atsushi Kumanogoh, Yasushi Sakata, Takeshi Ogo, Tadamitsu Kishimoto, Yoshikazu Nakaoka
Aryl hydrocarbon receptor is essential for the pathogenesis of pulmonary arterial hypertension. Proceedings of the National Academy of Sciences of the United States of America 118 (11) (2021)